Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Huya Inc ADR (NY: HUYA )

3.440 +0.020 (+0.58%)
Official Closing Price Updated: 7:00 PM EST, Dec 8, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Huya Inc ADR

< Previous 1 2 3 4 5 6 Next >
HUYA Plunges On 25% Topline Decline, Warning On Near Term Challenges
HUYA Inc (NYSE: HUYA) is down over 15% in Tuesday's trading session following its Q4 results. The company warned that it might face continued pressure from the volatile market environment in the near... 
Via Benzinga
11 Communication Services Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 21, 2023
Companies Reporting Before The Bell • LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.20 per share on revenue of $41.75 million. 
Via Benzinga
Preview: HUYA's Earnings
Via Benzinga
Expert Ratings for HUYA
Via Benzinga
Why Shares of Bilibili, HUYA, and New Oriental Education and Technology Are Falling Today
Several Chinese stocks lost ground in light of the latest macroeconomic and geopolitical news. 
Via The Motley Fool
Esperion Therapeutics And Other Big Stocks Moving Lower In Monday's Pre-Market Session
U.S. stock futures traded mixed this morning. Here are some big stocks recording losses in today’s pre-market trading session. 
Via Benzinga
7 Growth Stocks in the Gaming Industry With High Potential for Gains
With the digital entertainment industry continuing to expand, these are the gaming growth stocks for investors to consider. 
Via InvestorPlace
7 Stocks to Buy for the Future of E-Sports
With more people piling into digital entertainment, the future looks bright for esports. 
Via InvestorPlace
Why Meta Platforms Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket
Gainers Tenax Therapeutics, Inc (NASDAQ: TENX) shares rose 172.8% to $4.61 in pre-market trading. Tenax was granted a Notice of Allowance for U.S. Patent application for use of IV levosimendan in... 
Via Benzinga
Why Shares of Baozun, Hello Group, and HUYA Are Rising Today
Chinese stocks broadly are responding positively to some regulatory news and more bullishness around the sector. 
Via The Motley Fool
Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Nasdaq Down Over 100 Points; Procter & Gamble Posts In-Line Earnings
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 300 points on Thursday. 
Via Benzinga
Concert Pharmaceuticals, Coeur Mining And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping around 200 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Goldman Sachs, New Oriental Education & Technology And Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping around 300 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Stocks Aim For Weekly Wins Despite Bank Sector Pullback
Stocks are trading on both sides of the aisle today after JPMorgan Chase warned that a recession is the best-case scenario this year. 
Via Talk Markets
National Instruments, Virgin Galactic And Other Big Stocks Moving Higher On Friday
U.S. stocks traded slightly higher, with the Dow Jones gaining around 25 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
US Stocks Rise; Dow Gains 100 Points
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Wednesday. 
Via Benzinga
Why Shares Of Chinese Companies Are Trading Lower? Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
Gainers Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares gained 130.5% to $9.03 after the company announced FDA acceptance of a IND application for its KPI-012 for the treatment of persistent corneal... 
Via Benzinga
12 Communication Services Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Third Harmonic Bio Shares Are Trading Lower By Over 78%? Here Are 40 Stocks Moving In Thursday's Mid-Day Session
Gainers Crown ElectroKinetics Corp. (NASDAQ: CRKN) jumped 69.6% to $0.2604 after gaining 17% on Wednesday. Crown ElectroKinetics, last month, posted a Q3 loss of $0.18 per share. 
Via Benzinga
12 Communication Services Stocks Moving In Thursday's Intraday Session
Via Benzinga
10 Communication Services Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Harpoon Therapeutics Shares Are Trading Higher By 97%? Here Are 53 Stocks Moving In Monday's Mid-Day Session
Gainers HTG Molecular Diagnostics, Inc. (NASDAQ: HTGM) shares jumped 165.7% to $1.4350 after jumping around 118% on Friday. HTG Molecular Diagnostics, last month, posted a Q3 loss of $0.41 per share. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 13, 2022
Via Benzinga
RH, HUYA, Bilibili And Some Other Big Stocks Moving Lower On Monday
U.S. stocks traded higher, with the Dow Jones jumping more than 200 points on Monday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
Dow Tumbles 100 Points; Silver Rises Over 2%
U.S. stocks traded mostly lower toward the end of trading with the Dow Jones dropping 100 points on Friday 
Via Benzinga
US Stocks Turn Higher; Nasdaq Rises 40 Points
U.S. stocks traded slightly midway through trading with the Nasdaq gaining over 40 points on Friday 
Via Benzinga
Broadcom, DocuSign And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
Via Benzinga
Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session
Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.